-
Product Insights
Anterior Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Anterior Uveitis - Drugs In Development, 2023’, provides an overview of the Anterior Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anterior Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Humoral Hypercalcemia of Malignancy – Drugs In Development, 2023
Global Markets Direct’s, ‘Humoral Hypercalcemia of Malignancy - Drugs In Development, 2023’, provides an overview of the Humoral Hypercalcemia of Malignancy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Humoral Hypercalcemia of Malignancy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Giant Cell Tumor Of Bone – Drugs In Development, 2023
Global Markets Direct’s, ‘Giant Cell Tumor Of Bone - Drugs In Development, 2023’, provides an overview of the Giant Cell Tumor Of Bone pipeline landscape. The report provides comprehensive information on the therapeutics under development for Giant Cell Tumor Of Bone, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Bone Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Bone Tumor - Drugs In Development, 2023’, provides an overview of the Bone Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bone Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Polyarticular Juvenile Idiopathic Arthritis (PJIA) – Drugs In Development, 2023
Global Markets Direct’s, ‘Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Drugs In Development, 2023’, provides an overview of the Polyarticular Juvenile Idiopathic Arthritis (PJIA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polyarticular Juvenile Idiopathic Arthritis (PJIA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Hidradenitis Suppurativa – Drugs In Development, 2023
Global Markets Direct’s, ‘Hidradenitis Suppurativa - Drugs In Development, 2023’, provides an overview of the Hidradenitis Suppurativa pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hidradenitis Suppurativa, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Drugs In Development, 2023’, provides an overview of the Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Juvenile Arthritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Juvenile Arthritis - Drugs In Development, 2023’, provides an overview of the Juvenile Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Juvenile Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Ankylosing Spondylitis Clinical Trial Analysis Report Overview A total of 1,072 Ankylosing Spondylitis clinical trials were conducted as of January 2024. The Ankylosing Spondylitis clinical trial report provides a comprehensive understanding of the Ankylosing Spondylitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       ...
-
Product Insights
Psoriatic Arthritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Psoriatic Arthritis - Drugs In Development, 2023’, provides an overview of the Psoriatic Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...